This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Special Lecture in Honor of Dr. Charles C. Dennie

C. Gordon Zubrod, MD

Arch Dermatol. 1967;96(5):560-564.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE CHEMOTHERAPY of cancer has developed rapidly in the last few years, and I should like in this discussion to mention briefly some of the implications of this growing body of knowledge for dermatology and for the dermatologist. I shall first describe the effects of antitumor drugs on normal skin, on tumors of the skin, and upon diseases other than cancer, and then review some of the conceptual advances in cancer chemotherapy. I have omitted any discussion of the antitumor hormones.

A large number of patients in this country are receiving antitumor drugs and this number is increasing rapidly. Consultants will see an ever increasing number of patients receiving these agents and should be aware of their potentialities. An excellent summary for quick reference purposes appeared in a recent Medical Letter.1 The Table shows the antitumor drugs approved for commercial distribution, and those under investigational study likely to . . . [Full Text PDF of this Article]

Author Affiliations
Bethesda, Md

From the National Cancer Institute, Bethesda, Md.

Footnotes
Accepted for publication July 10, 1967.

Read before the American Dermatological Association, Inc., Colorado Springs, Colo, May 28-31, 1967.

Reprint requests to the National Cancer Institute, Bethesda, Md 20014 (Dr. Zubrod).

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter     What's this?